Upgrade to SI Premium - Free Trial

Research Growth, AI Momentum, and Margin Expansion Highlight Wiley’s Second Quarter 2026

December 4, 2025 7:30 AM

HOBOKEN, N.J.--(BUSINESS WIRE)-- Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025.

SECOND QUARTER SUMMARY

MANAGEMENT COMMENTARY

“We continue to deliver strong performance in Research and accelerating momentum in AI as we capitalize on record research volume and expanding corporate R&D opportunities,” said Matthew Kissner, President and CEO. “In Research, strong global demand is driving defensible growth in our recurring revenue and open access models. In AI, we are turning high-value knowledge into impact through the execution of content licensing projects for large language models and corporate AI applications. Finally, operational excellence and margin expansion are a way of life for us as we continuously optimize our cost structure, drive investment and expense discipline, and advance our transformative publishing platform.”

FINANCIAL SUMMARY

Please see the accompanying financial tables for more detail.

Research

Learning

Corporate Expenses

“Corporate Expenses” are the portion of shared services costs not allocated to segments.

EPS

BALANCE SHEET, CASH FLOW, AND CAPITAL ALLOCATION

FISCAL 2026 OUTLOOK

Wiley is reaffirming its full year outlook for Adjusted EBITDA margin, Adjusted EPS, and Free Cash Flow and narrowing its Revenue guidance to the low end of the range due to market challenges in Learning. Research and AI momentum are expected to remain strong. The revenue range is narrowed to low-single digit growth from low-to-mid single digit growth.

Metric

Fiscal 2024 Results

Fiscal 2025 Results

Fiscal 2026 Outlook

Adj. Revenue

$1,617M

$1,660M

Low-single digit growth*

Adj. EBITDA Margin

22.8%

24%

25.5% to 26.5%

Adj. EPS

$2.78

$3.64

$3.90 to $4.35

Free Cash Flow

$114M

$126M

Approximately $200M

*Narrowed from low-to-mid single digit growth

Adjusted metrics exclude impact of divestitures, which were primarily completed in Fiscal 2024 with remainder completed in first half of Fiscal 2025. Approximately $17 million of divestiture-related revenue was recorded in Fiscal 2025.

EARNINGS CONFERENCE CALL

Scheduled for today, December 4 at 10:00 am (ET). Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606. U.S. callers, please dial (888) 210-3346 and enter the participant code 2521217#. International callers, please dial (646) 960-0253 and enter the participant code 2521217#.

ABOUT WILEY

Wiley (NYSE: WLY) is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.

NON-GAAP FINANCIAL MEASURES

Wiley provides non-GAAP financial measures and performance results such as “Adjusted EPS,” “Adjusted Operating Income and Margin,” “EBITDA, Adjusted EBITDA and Margin,” “Adjusted Income before Taxes,” “Adjusted Income Tax Provision,” “Adjusted Effective Tax Rate,” “Free Cash Flow less Product Development Spending,” “Adjusted Revenue,” and results on a Constant Currency basis to assess underlying business performance and trends. Management believes non-GAAP financial measures, which exclude the impact of restructuring charges and credits and certain other items, and the impact of divestitures and acquisitions provide a useful comparable basis to analyze operating results and earnings. See the reconciliations of non-GAAP financial measures and explanations of the uses of non-GAAP measures in the supplementary information. We have not provided our 2026 outlook for the most directly comparable U.S. GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain items, including restructuring charges and credits, gains and losses on foreign currency, and other gains and losses. These items are uncertain, depend on various factors, and could be material to our consolidated results computed in accordance with U.S. GAAP.

FORWARD-LOOKING STATEMENTS

This release contains certain forward-looking statements concerning the Company's operations, performance, and financial condition. Reliance should not be placed on forward-looking statements, as actual results may differ materially from those in any forward-looking statements. Any such forward-looking statements are based upon a number of assumptions and estimates that are inherently subject to uncertainties and contingencies, many of which are beyond the control of the Company and are subject to change based on many important factors. Such factors include, but are not limited to: (i) the level of investment in new technologies and products; (ii) subscriber renewal rates for the Company's journals; (iii) the financial stability and liquidity of journal subscription agents; (iv) the consolidation of book wholesalers and retail accounts; (v) the market position and financial stability of key online retailers; (vi) the seasonal nature of the Company's educational business and the impact of the used book market; (vii) worldwide economic and political conditions; (viii) the Company's ability to protect its copyrights and other intellectual property worldwide (ix) the ability of the Company to successfully integrate acquired operations and realize expected opportunities; (x) the ability to realize operating savings over time and in fiscal year 2026 in connection with our multiyear Global Restructuring Program and completed dispositions; (xi) cyber risk and the failure to maintain the integrity of our operational or security systems or infrastructure, or those of third parties with which we do business; (xii) as a result of acquisitions, we have and may record a significant amount of goodwill and other identifiable intangible assets and we may never realize the full carrying value of these assets; (xiii) our ability to leverage artificial intelligence technologies in our products and services, including generative artificial intelligence, large language models, machine learning, and other artificial intelligence tools; and (xiv) other factors detailed from time to time in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise forward-looking statements to reflect subsequent events.

CATEGORY: EARNINGS RELEASES

JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION (1) (2)
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME
(in USD thousands, except per share information)
(unaudited)
Three Months Ended Six Months Ended
October 31, October 31,

2025

2024

2025

2024

Revenue, net

$

421,751

$

426,595

$

818,551

$

830,404

Costs and expenses:
Cost of sales

104,388

107,000

213,647

216,220

Operating and administrative expenses

225,087

238,891

465,417

487,710

Restructuring and related charges

6,032

3,627

9,070

7,497

Amortization of intangible assets

13,248

12,944

26,458

25,871

Total costs and expenses

348,755

362,462

714,592

737,298

Operating income

72,996

64,133

103,959

93,106

As a % of revenue

17.3

%

15.0

%

12.7

%

11.2

%

Interest expense

(11,670

)

(14,463

)

(22,712

)

(27,250

)

Net foreign exchange transaction gains (losses)

956

(3,328

)

(15

)

(3,094

)

Net (loss) gain on sale of businesses, assets, and impairment charges related to assets held-for-sale

(2,309

)

369

(3,425

)

6,170

Other (expense) income, net

(1,963

)

2,226

(2,090

)

3,008

Income before taxes

58,010

48,937

75,717

71,940

Provision for income taxes

13,119

8,479

19,126

32,918

Effective tax rate

22.6

%

17.3

%

25.3

%

45.8

%

Net income

$

44,891

$

40,458

$

56,591

$

39,022

As a % of revenue

10.6

%

9.5

%

6.9

%

4.7

%

Earnings per share
Basic

$

0.85

$

0.75

$

1.06

$

0.72

Diluted

$

0.84

$

0.74

$

1.05

$

0.71

Weighted average number of common shares outstanding
Basic

53,089

54,191

53,233

54,284

Diluted

53,515

54,850

53,735

54,928

Notes:
(1) The supplementary information included in this press release for the three and six months ended October 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
(2) All amounts are approximate due to rounding.
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION (1) (2)
RECONCILIATION OF US GAAP MEASURES to NON-GAAP MEASURES
(in USD thousands, except per share information)
(unaudited)
Reconciliation of US GAAP Earnings per Share to Non-GAAP Adjusted EPS
Three Months Ended Six Months Ended
October 31, October 31,

2025

2024

2025

2024

US GAAP Earnings Per Share - Diluted

$

0.84

$

0.74

$

1.05

$

0.71

Adjustments:
Restructuring and related charges

0.09

0.06

0.14

0.12

Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments

(0.02

)

0.04

(0.01

)

-

Amortization of acquired intangible assets

0.22

0.21

0.42

0.40

Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

0.04

-

0.06

(0.08

)

Held for Sale or Sold segment Adjusted Net Loss

-

0.01

-

0.05

Legal settlement

-

-

-

-

Income tax adjustments

(0.07

)

(0.09

)

(0.07

)

0.24

Non-GAAP Adjusted Earnings Per Share - Diluted

$

1.10

$

0.97

$

1.59

$

1.44

Reconciliation of US GAAP Income Before Taxes to Non-GAAP Adjusted Income Before Taxes
Three Months Ended Six Months Ended
October 31, October 31,

2025

2024

2025

2024

US GAAP Income Before Taxes

$

58,010

$

48,937

$

75,717

$

71,940

Pretax Impact of Adjustments:
Restructuring and related charges

6,032

3,627

9,070

7,497

Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments

(1,111

)

2,943

(1,550

)

351

Amortization of acquired intangible assets

13,248

12,944

26,458

25,913

Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

2,309

(369

)

3,425

(6,170

)

Held for Sale or Sold segment Adjusted Loss Before Taxes

-

1,059

-

3,578

Legal settlement

108

-

108

-

Non-GAAP Adjusted Income Before Taxes

$

78,596

$

69,141

$

113,228

$

103,109

Reconciliation of US GAAP Income Tax Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate
US GAAP Income Tax Provision

$

13,119

$

8,479

$

19,126

$

32,918

Income Tax Impact of Adjustments (3)
Restructuring and related charges

1,271

161

1,790

911

Foreign exchange (gains) losses on intercompany transactions, including the write off of certain cumulative translation adjustments

(217

)

729

(967

)

338

Amortization of acquired intangible assets

2,133

1,792

4,126

3,601

Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

-

(588

)

54

(1,513

)

Held for Sale or Sold segment Adjusted Tax Benefit

-

515

-

887

Legal settlement

-

-

-

-

Income Tax Adjustments
Impact of valuation allowance on the US GAAP effective tax rate

(212

)

4,911

29

(13,119

)

Impact of change in Germany statutory tax rate on deferred tax balances

3,869

-

3,869

-

Non-GAAP Adjusted Income Tax Provision

$

19,963

$

15,999

$

28,027

$

24,023

US GAAP Effective Tax Rate

22.6

%

17.3

%

25.3

%

45.8

%

Non-GAAP Adjusted Effective Tax Rate

25.4

%

23.1

%

24.8

%

23.3

%

Notes:
(1) All amounts are approximate due to rounding.
(2) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors.
(3) For the three and six months ended October 31, 2025 and 2024, respectively, substantially all of the tax impact was from deferred taxes.
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION (1)(2)
RECONCILIATION OF US GAAP NET INCOME TO NON-GAAP EBITDA AND ADJUSTED EBITDA
(in USD thousands)
(unaudited)
Three Months Ended Six Months Ended
October 31, October 31,

2025

2024

2025

2024

Net Income

$

44,891

$

40,458

$

56,591

$

39,022

Interest expense

11,670

14,463

22,712

27,250

Provision for income taxes

13,119

8,479

19,126

32,918

Depreciation and amortization

35,929

36,718

72,375

73,971

Non-GAAP EBITDA

105,609

100,118

170,804

173,161

Restructuring and related charges

6,032

3,627

9,070

7,497

Net foreign exchange transaction (gains) losses

(956

)

3,328

15

3,094

Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

2,309

(369

)

3,425

(6,170

)

Other expense (income), net

1,963

(2,226

)

2,090

(3,008

)

Held for Sale or Sold segment Adjusted EBITDA

-

1,059

-

3,578

Legal settlement

108

-

108

-

Non-GAAP Adjusted EBITDA

$

115,065

$

105,537

$

185,512

$

178,152

Adjusted EBITDA Margin

27.3

%

24.9

%

22.7

%

21.9

%

Notes:
(1) All amounts are approximate due to rounding.
(2) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors.
JOHN WILEY & SONS, INC.

SUPPLEMENTARY INFORMATION (1) (2) (3)

SEGMENT RESULTS
(in USD thousands)
(unaudited)
% Change
Three Months Ended October 31, Favorable (Unfavorable)

2025

2024

Reported Constant
Currency
Research:
Revenue, net
Research Publishing

$

241,382

$

222,667

8%

7%

Research Solutions

37,132

39,218

-5%

-6%

Total Revenue, net

$

278,514

$

261,885

6%

5%

Non-GAAP Adjusted Operating Income

$

69,961

$

59,527

18%

16%

Depreciation and amortization

23,319

22,522

-4%

-2%

Non-GAAP Adjusted EBITDA

$

93,280

$

82,049

14%

13%

Adjusted EBITDA margin

33.5

%

31.3

%

Learning:
Revenue, net
Academic

$

87,030

$

94,788

-8%

-8%

Professional

56,207

66,726

-16%

-16%

Total Revenue, net

$

143,237

$

161,514

-11%

-11%

Non-GAAP Adjusted Operating Income

$

46,755

$

55,871

-16%

-16%

Depreciation and amortization

10,680

10,897

2%

2%

Non-GAAP Adjusted EBITDA

$

57,435

$

66,768

-14%

-14%

Adjusted EBITDA margin

40.1

%

41.3

%

Held for Sale or Sold:
Total Revenue, net

$

-

$

3,196

# #
Non-GAAP Adjusted Operating Loss

$

-

$

(1,059

)

# #
Depreciation and amortization

-

-

# #
Non-GAAP Adjusted EBITDA

$

-

$

(1,059

)

# #
Adjusted EBITDA margin

0.0

%

-33.1

%

Corporate Expenses:
Non-GAAP Adjusted Corporate Expenses

$

(37,580

)

$

(46,579

)

19%

20%

Depreciation and amortization

1,930

3,299

41%

42%

Non-GAAP Adjusted EBITDA

$

(35,650

)

$

(43,280

)

18%

18%

Consolidated Results:
Revenue, net

$

421,751

$

426,595

-1%

-2%

Less: Held for Sale or Sold Segment

-

(3,196

)

# #
Adjusted Revenue, net

$

421,751

$

423,399

0%

-1%

Operating Income

$

72,996

$

64,133

14%

13%

Adjustments:
Restructuring charges

6,032

3,627

-66%

-66%

Held for Sale or Sold Segment Adjusted Operating Loss

-

1,059

# #
Legal settlement

108

-

# #
Non-GAAP Adjusted Operating Income

$

79,136

$

68,819

15%

14%

Adjusted Operating Income margin

18.8

%

16.3

%

Depreciation and amortization

35,929

36,718

2%

3%

Less: Held for Sale or Sold Segment depreciation and amortization

-

-

# #
Non-GAAP Adjusted EBITDA

$

115,065

$

105,537

9%

8%

Adjusted EBITDA margin

27.3

%

24.9

%

Notes:
(1) The supplementary information included in this press release for the three and six months ended October 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
(2) All amounts are approximate due to rounding.
(3) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors.
# Variance greater than 100%
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION (1) (2) (3)
SEGMENT RESULTS
(in USD thousands)
(unaudited)
% Change
Six Months Ended October 31, Favorable (Unfavorable)

2025

2024

Reported Constant
Currency
Research:
Revenue, net
Research Publishing

$

473,209

$

453,618

4%

3%

Research Solutions

86,997

73,576

18%

17%

Total Revenue, net

$

560,206

$

527,194

6%

5%

Non-GAAP Adjusted Operating Income

$

126,209

$

114,743

10%

10%

Depreciation and amortization

46,704

45,081

-4%

-2%

Non-GAAP Adjusted EBITDA

$

172,913

$

159,824

8%

8%

Adjusted EBITDA margin

30.9

%

30.3

%

Learning:
Revenue, net
Academic

$

142,502

$

154,752

-8%

-8%

Professional

115,843

131,076

-12%

-12%

Total Revenue, net

$

258,345

$

285,828

-10%

-10%

Non-GAAP Adjusted Operating Income

$

68,410

$

78,371

-13%

-13%

Depreciation and amortization

20,524

22,191

8%

8%

Non-GAAP Adjusted EBITDA

$

88,934

$

100,562

-12%

-12%

Adjusted EBITDA margin

34.4

%

35.2

%

Held for Sale or Sold:
Total Revenue, net

$

-

$

17,382

# #
Non-GAAP Adjusted Operating Loss

$

-

$

(3,578

)

# #
Depreciation and amortization

-

-

# #
Non-GAAP Adjusted EBITDA

$

-

$

(3,578

)

# #
Adjusted EBITDA margin

0.0

%

-20.6

%

Corporate Expenses:
Non-GAAP Adjusted Corporate Expenses

$

(81,482

)

$

(88,933

)

8%

9%

Depreciation and amortization

5,147

6,699

23%

23%

Non-GAAP Adjusted EBITDA

$

(76,335

)

$

(82,234

)

7%

8%

Consolidated Results:
Revenue, net

$

818,551

$

830,404

-1%

-2%

Less: Held for Sale or Sold Segment

-

(17,382

)

# #
Adjusted Revenue, net

$

818,551

$

813,022

1%

0%

Operating Income

$

103,959

$

93,106

12%

12%

Adjustments:
Restructuring charges

9,070

#

7,497

-21%

-21%

Held for Sale or Sold Segment Adjusted Operating Loss

-

3,578

# #
Legal settlement

108

-

# #
Non-GAAP Adjusted Operating Income

$

113,137

$

104,181

9%

9%

Adjusted Operating Income margin

13.8

%

12.8

%

Depreciation and amortization

72,375

73,971

2%

3%

Less: Held for Sale or Sold depreciation and amortization

-

-

# #
Non-GAAP Adjusted EBITDA

$

185,512

$

178,152

4%

4%

Adjusted EBITDA margin

22.7

%

21.9

%

# Variance greater than 100%
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION (1) (2)
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(in USD thousands)
(unaudited)
October 31, April 30,

2025

2025

Assets:
Current assets
Cash and cash equivalents

$

67,404

$

85,882

Accounts receivable, net

209,679

228,410

Inventories, net

21,387

22,875

Prepaid expenses and other current assets

82,753

102,717

Total current assets

381,223

439,884

Technology, property and equipment, net

146,796

162,125

Intangible assets, net

581,998

595,044

Goodwill

1,116,174

1,121,505

Operating lease right-of-use assets

62,152

66,128

Other non-current assets

178,396

306,780

Total assets

$

2,466,739

$

2,691,466

Liabilities and shareholders' equity:
Current liabilities
Accounts payable

$

47,654

$

60,948

Accrued royalties

126,130

109,765

Short-term portion of long-term debt

10,000

10,000

Contract liabilities

218,787

462,693

Accrued employment costs

52,796

93,117

Short-term portion of operating lease liabilities

16,636

18,282

Other accrued liabilities

68,348

66,051

Total current liabilities

540,351

820,856

Long-term debt

861,713

789,435

Accrued pension liability

72,053

71,899

Deferred income tax liabilities

102,986

105,145

Operating lease liabilities

76,278

81,482

Other long-term liabilities

73,169

70,443

Total liabilities

1,726,550

1,939,260

Shareholders' equity

740,189

752,206

Total liabilities and shareholders' equity

$

2,466,739

$

2,691,466

Notes:
(1) The supplementary information included in this press release for October 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
(2) All amounts are approximate due to rounding.
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION (1) (2)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in USD thousands)
(unaudited)
Six Months Ended
October 31,

2025

2024

Operating activities:
Net income

$

56,591

$

39,022

Net loss (gain) on sale of businesses, assets, and impairment charges related to assets held-for-sale

3,425

(6,170

)

Amortization of intangible assets

26,458

25,871

Amortization of product development assets

7,663

8,622

Depreciation and amortization of technology, property, and equipment

38,254

39,478

Other noncash charges

40,325

45,638

Net change in operating assets and liabilities

(249,221

)

(246,453

)

Net cash used in operating activities

(76,505

)

(93,992

)

Investing activities:
Additions to technology, property, and equipment

(25,125

)

(29,030

)

Product development spending

(6,296

)

(7,127

)

Businesses acquired in purchase transactions, net of cash acquired

-

(915

)

Net cash proceeds (transferred) related to the sale of businesses and assets

114,132

(8,117

)

Acquisitions of publication rights and other

(10,273

)

700

Net cash provided by (used in) investing activities

72,438

(44,489

)

Financing activities:
Net debt borrowings

75,501

184,066

Cash dividends

(37,772

)

(38,264

)

Purchases of treasury shares

(35,085

)

(25,421

)

Other

(15,617

)

(7,298

)

Net cash (used in) provided by financing activities

(12,973

)

113,083

Effects of exchange rate changes on cash, cash equivalents and restricted cash

(1,438

)

1,441

Change in cash, cash equivalents and restricted cash for period

(18,478

)

(23,957

)

Cash, cash equivalents and restricted cash - beginning

85,932

99,543

Cash, cash equivalents and restricted cash - ending

$

67,454

$

75,586

CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING (3)
Six Months Ended
October 31,

2025

2024

Net cash used in operating activities

$

(76,505

)

$

(93,992

)

Less: Additions to technology, property, and equipment

(25,125

)

(29,030

)

Less: Product development spending

(6,296

)

(7,127

)

Free cash flow less product development spending

$

(107,926

)

$

(130,149

)

Notes:
(1) The supplementary information included in this press release for the six months ended October 31, 2025 is preliminary and subject to change prior to the filing of our upcoming Quarterly Report on Form 10-Q with the Securities and Exchange Commission.
(2) All amounts are approximate due to rounding.
(3) See Explanation of Usage of Non-GAAP Performance Measures included in this supplementary information for additional details on the reasons why management believes presentation of each non-GAAP performance measure provides useful information to investors.

JOHN WILEY & SONS, INC.
EXPLANATION OF USAGE OF NON-GAAP PERFORMANCE MEASURES

In this earnings release and supplemental information, management may present the following non-GAAP performance measures:

Management uses these non-GAAP performance measures as supplemental indicators of our operating performance and financial position as well as for internal reporting and forecasting purposes, when publicly providing our outlook, to evaluate our performance and calculate incentive compensation.

We present these non-GAAP performance measures in addition to US GAAP financial results because we believe that these non-GAAP performance measures provide useful information to certain investors and financial analysts for operational trends and comparisons over time. The use of these non-GAAP performance measures may also provide a consistent basis to evaluate operating profitability and performance trends by excluding items that we do not consider to be controllable activities for this purpose.

The performance metric used by our chief operating decision maker to evaluate performance of our reportable segments is Adjusted Operating Income. We present both Adjusted Operating Income and Adjusted EBITDA for each of our reportable segments as we believe Adjusted EBITDA provides additional useful information to certain investors and financial analysts for operational trends and comparisons over time. It removes the impact of depreciation and amortization expense, as well as presents a consistent basis to evaluate operating profitability and compare our financial performance to that of our peer companies and competitors.

For example:

In addition, we have historically provided these or similar non-GAAP performance measures and understand that some investors and financial analysts find this information helpful in analyzing our operating margins and net income, and in comparing our financial performance to that of our peer companies and competitors. Based on interactions with investors, we also believe that our non-GAAP performance measures are regarded as useful to our investors as supplemental to our US GAAP financial results, and that there is no confusion regarding the adjustments or our operating performance to our investors due to the comprehensive nature of our disclosures.

We have not provided our 2026 outlook for the most directly comparable US GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain items, including restructuring charges and credits, gains and losses on foreign currency, and other gains and losses. These items are uncertain, depend on various factors, and could be material to our consolidated results computed in accordance with US GAAP.

Non-GAAP performance measures do not have standardized meanings prescribed by US GAAP and therefore may not be comparable to the calculation of similar measures used by other companies and should not be viewed as alternatives to measures of financial results under US GAAP. The adjusted metrics have limitations as analytical tools, and should not be considered in isolation from, or as a substitute for, US GAAP information. It does not purport to represent any similarly titled US GAAP information and is not an indicator of our performance under US GAAP. Non-GAAP financial metrics that we present may not be comparable with similarly titled measures used by others. Investors are cautioned against placing undue reliance on these non-GAAP measures.

Brian Campbell

Investor Relations

[email protected]

201.748.6874

Source: John Wiley and Sons

Categories

Business Wire Press Releases

Next Articles